{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T20:04:59Z","timestamp":1774555499587,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jdermsci.2022.02.003","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T11:47:38Z","timestamp":1644234458000},"page":"159-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Qa-1b functions as an oncogenic factor in mouse melanoma cells"],"prefix":"10.1016","volume":"105","author":[{"given":"Xiang","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congfang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiduan","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongfen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiwen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2022.02.003_bib1","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.3390\/ijms21238984","article-title":"Overcoming immune evasion in melanoma","volume":"21","author":"Eddy","year":"2020","journal-title":"Int .J. Mol. Sci."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/path.5505","article-title":"Spontaneously occurring melanoma in animals and their relevance to human melanoma","volume":"252","author":"Van der Weyden","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jamadermatol.2019.3353","article-title":"Age-specific incidence of melanoma in the United States","volume":"156","author":"Paulson","year":"2020","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib4","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA: A Cancer J. Clin."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib5","unstructured":"Matthews NH, Li WQ, Qureshi AA, Weinstock MA, Cho E.: Epidemiology of Melanoma. 2017."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib6","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.cell.2018.10.028","article-title":"NKG2A blockade potentiates CD8 T cell immunity induced by cancer vaccines","volume":"175","author":"Van Montfoort","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib7","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.18632\/oncotarget.6506","article-title":"The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma","volume":"7","author":"Talebian Yazdi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib8","doi-asserted-by":"crossref","first-page":"10656","DOI":"10.1073\/pnas.1100354108","article-title":"HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes","volume":"108","author":"Gooden","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib9","article-title":"Non-classical HLA-class I expression in serous ovarian carcinoma: correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis","volume":"5","author":"Andersson","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib10","first-page":"1487","article-title":"Expression of the nonclassical HLA-G and HLA-E molecules in laryngeal lesions as biomarkers of tumor invasiveness","volume":"26","author":"Silva","year":"2011","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1084\/jem.192.5.613","article-title":"Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94\/NKG2A to discriminate between Qa-1-peptide complexes","volume":"192","author":"Kraft","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib12","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.4049\/jimmunol.158.5.2183","article-title":"Dominance of a single peptide bound to the class I(B) molecule, Qa-1b","volume":"158","author":"DeCloux","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib13","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.cell.2015.08.052","article-title":"Melanoma\u00a0cell-intrinsic PD-1 receptor functions promote tumor growth","volume":"162","author":"Kleffel","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib14","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.cell.2018.11.048","article-title":"NKG2A, a new kid on the immune checkpoint block","volume":"175","author":"Haanen","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib15","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.immuni.2015.11.005","article-title":"The inhibitory receptor NKG2A sustains virus-specific CD8+ T cells in response to a lethal poxvirus infection","volume":"43","author":"Rapaport Aaron","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.gastro.2012.10.039","article-title":"Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice","volume":"144","author":"Li","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.immuni.2007.05.006","article-title":"Good news, bad news for missing-self recognition by NK cells: autoimmune control but viral evasion","volume":"26","author":"Vivier","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2007.03.017","article-title":"Regulation of activated CD4+ T cells by NK cells via the Qa-1\u2013NKG2A inhibitory pathway","volume":"26","author":"Lu","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00403-012-1223-7","article-title":"Upcoming strategies for the treatment of metastatic melanoma","volume":"304","author":"Spagnolo","year":"2012","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib20","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1073\/pnas.1918950117","article-title":"Regulatory CD8 T cells that recognize Qa-1 expressed by CD4 T-helper cells inhibit rejection of heart allografts","volume":"117","author":"Choi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010312","article-title":"Gene expression-based classification of non-small cell lung carcinomas and survival prediction","volume":"5","author":"Hou","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib22","first-page":"163","article-title":"Melanoma development: current knowledge on melanoma pathogenesis","volume":"27","author":"Lugovi\u0107-Mihi\u0107","year":"2019","journal-title":"Acta Dermatovenerol. Croatica"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib23","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1038\/nrdp.2015.3","article-title":"Melanoma","volume":"1","author":"Schadendorf","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14728222.2011.645805","article-title":"Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy","volume":"16","author":"Santarpia","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2016.01.012","article-title":"PI3K\/Akt\/mTOR and Ras\/Raf\/MEK\/ERK signaling pathways inhibitors as anticancer agents: structural and pharmacological perspectives","volume":"109","author":"Asati","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib26","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033746","article-title":"Ras-mediated activation of the raf family kinases","volume":"9","author":"Terrell","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib27","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib28","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib29","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1038\/s41467-019-12801-6","article-title":"YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression","volume":"10","author":"Shi","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.stem.2009.05.026","article-title":"Cdk4\/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors","volume":"5","author":"Lange","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature23465","article-title":"CDK4\/6 inhibition triggers anti-tumour immunity","volume":"548","author":"Goel","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.trecan.2018.07.002","article-title":"Protein-protein interactions: emerging oncotargets in the RAS-ERK pathway","volume":"4","author":"Garc\u00eda-G\u00f3mez","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pharmthera.2017.02.006","article-title":"Targeting TRK family proteins in cancer","volume":"173","author":"Khotskaya","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib35","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3892\/ol.2017.5557","article-title":"Targeting the Ras\/Raf\/MEK\/ERK pathway in hepatocellular carcinoma","volume":"13","author":"Yang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib36","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.2011.41.2452","article-title":"BRAF\/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma","volume":"30","author":"Colombino","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.cmr.0000232300.22032.86","article-title":"NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing","volume":"16","author":"Edlundh-Rose","year":"2006","journal-title":"Melanoma Res."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib38","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib39","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/sj.onc.1210394","article-title":"Integrating signals from RTKs to ERK\/MAPK","volume":"26","author":"McKay","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152701","article-title":"Apigenin, a flavonoid constituent derived from P. villosa, inhibits hepatocellular carcinoma cell growth by CyclinD1\/CDK4 regulation via p38 MAPK-p21 signaling","volume":"216","author":"Li","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2184.2008.00576.x","article-title":"Myc down-regulation affects cyclin D1\/cdk4 activity and induces apoptosis via Smac\/Diablo pathway in an astrocytoma cell line","volume":"42","author":"Amendola","year":"2009","journal-title":"Cell Prolif."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.tcb.2018.07.002","article-title":"CDK4\/6 inhibition in cancer: beyond cell cycle arrest","volume":"28","author":"Goel","year":"2018","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib43","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.21037\/apm-20-288","article-title":"Ligustrazine induces the colorectal cancer cells apoptosis via p53-dependent mitochondrial pathway and cell cycle arrest at the G0\/G1 phase","volume":"10","author":"Bian","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.jdermsci.2022.02.003_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11120731","article-title":"The cytotoxicity effect of resveratrol: cell cycle arrest and induced apoptosis of breast cancer 4T1 cells","volume":"11","author":"Wu","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.jdermsci.2022.02.003_bib45","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/DAD.0000000000000317","article-title":"MAP kinase pathways: molecular roads to primary acral lentiginous melanoma","volume":"37","author":"Fernandes","year":"2015","journal-title":"Am. J. Dermatopathol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181122000342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181122000342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:52:16Z","timestamp":1760331136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181122000342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0923181122000342"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2022.02.003","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Qa-1b functions as an oncogenic factor in mouse melanoma cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2022.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}